ERBB2 and breast carcinoma: On the other hand, the dual inhibition of PI3K and MAPK cascades can result in synergistic effects on cell proliferation and apoptosis in multiple cancer models [15], including HER2+ breast cancer [16,17], suggesting a potential role of MAPK signaling in the growth and survival of HER2+ cancers.